Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma - Rosiñol, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Hebraud, Benjamin (Institut Universitaire du Cancer de Toulouse-Oncopole) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Colin, Anne-Laurène (Ser Centre Hospitalier et Universitaire de Toulouse) ; Ríos Tamayo, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Hulin, Cyrille (Department of Hematology. Hôpital Haut-Lévêque) ; Blanchard, María Jesús (Hospital Universitario Ramón y Cajal (Madrid)) ; Caillot, Denis (Hôpital du Bocage) ; Sureda, Anna (Universitat de Barcelona) ; Hernández, Miguel Teodoro (Hospital Universitario de Canarias (La Laguna)) ; Arnulf, Bertrand (Hôpital St-Louis) ; Mateos, M. V (Instituto de Investigación Biomédica de Salamanca) ; Macro, Margaret (Centre Hospitalier et Universitaire de Caen) ; San-Miguel, J (Clínica Universidad de Navarra) ; Belhadj, Karim (Centre Hospitalier et Universitaire Henri Mondor) ; Lahuerta, J. J (Clínica Universidad de Navarra) ; Garelik, M.Brigid (Bristol-Myers Squibb Company) ; Bladé Creixenti, Juan (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Moreau, Philippe (University Hospital Hôtel-Dieu, Nantes, France)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>